滚动资讯
Lonza NewsBRIEF—Lonza and Genetix Biotherapeutics extend deal - The Pharma LetterEndpoints NewsIpsen pulls cancer drug Tazverik from market over safety risksEndpoints NewsWhat Prasad's exit means for the FDA moving forwardAgilent安捷伦科技以9.5亿美元收购Biocare Medical - 雅虎财经BioPharma DiveRoche’s prized breast cancer pill fails closely watched studyFierceBiotechTenacia与Rapport达成3.08亿美元生物技术协议，共同开发大中华区癫痫药物。FierceBiotechFDA批准备用防窒息吸痰装置FierceBiotech氙气三期癫痫试验结果远超预期，股价飙升。FierceBiotech百时美施贵宝在骨髓瘤三期试验中改善无进展生存期，为CELMoD药物注入新动力。BioPharma DiveUniQure leads genetic medicine biotech rally after news of Prasad’s exitAgilent安捷伦以9.5亿美元收购Biocare Medical - MedTech DiveBioPharma Dive益普生因安全问题将撤回收购所得抗癌药物
Agilent 2026年3月9日

安捷伦以9.5亿美元收购Biocare Medical - MedTech Dive

安捷伦以9.5亿美元收购Biocare Medical - MedTech Dive

原文
暂时没有全文，请查看原始来源。

目录

59 全部